Vagal stimulation -A new possibility for conservative treatment of peripheral arterial occlusion disease;Vagale Stimulation -eine neue Möglichkeit zur konservativen Therapie der peripheren arteriellen Verschlusskrankheit

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 136, Issue 5, 2011, Pages 431-435

  Payrits, T ^a   Ernst, A ^a   Ladits, E ^a   Pokorny, H ^a   Viragos, I ^a   Langle F ^a  

^a Chirurgie   (Austria)

Author keywords

conservative treatment; peripheral arterial occlusion disease; vagal stimulation; vascular surgery

Indexed keywords

AGED; ARTICLE; CASE REPORT; ELECTRODE; EQUIPMENT DESIGN; FEMALE; HUMAN; INSTRUMENTATION; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; VAGUS NERVE STIMULATION; VASCULARIZATION; WALKING;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; VAGUS NERVE STIMULATION; WALKING;

EID: 80054861884     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0031-1283739     Document Type: Article

References (23)

1. Diehm C, Schuster A, Allenberg J R. et al. High prevalence of peripheral arterial disease and co-morbidity in 6880primary care patients: cross-sectional study. Atherosclerosis 2004 172 95-105 (Pubitemid 38058606)
2. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlußkrankheit PAVK. AWMF-Register Nr.065/003
3. Norgren L, Hiatt W, Dormandy J et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASCII). Eur J Vasc Endovasc Surg 2007 33 S1-S75 (Pubitemid 46068992)
4. Arzneimittelkommission der deutschen Ärzteschaft. Handlungsleitlinie PAVK aus Empfehlungen zur Therapie der peripheren arteriellen Verschlußkrankheit. 3. Auflage Arzneiverordnung in der Praxis Band 31 Sonderheft 3 2004
5. Hirsch A T., Haskal Z J., Hertzer N R. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006 113 e463-e654
6. Steinacker J, Liu Y, Hanke H. Körperliche Bewegung bei peripherer arterieller Verschlußkrankheit. Deutsches Ärzteblatt 2002 45 2550-2554
7. Bendermacher B L., Willigendael E M., Teijink J A. et al. Supervised exercise therapy versus nonsupervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006 CD005263
8. Katzel L I., Sorkin J D., Powell C C. et al. Comorbidities and exercise capacity in older patients with intermittent claudication. Vasc Med 2001 3 157-162 (Pubitemid 33138278)
9. Regensteiner J G., Ware Jr J E., McCarthy W J. et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 2002 50 1939-1946 (Pubitemid 35462438)
10. Boccalon H, Lehert P, Mosnier M. Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication. Ann Cardiol Angeiol (Paris) 2001 50 175-182 (Pubitemid 32318776)
11. De Backer T L., Vander Stichele R, Lehert P et al. Naftidrofuryl for intermittent claudication. Cochrane Database Syst Rev 2008 CD001368
12. Menzonian J. Major leg amputations in patients with severe peripheral arterial occlusive disease (PAD) not amenable to revascularization procedures: results of a randomized, placebo-controlled multicenter study with alprostadil. 17thWorld Congress of the International Union of Angiology (IUA). Abstract book London 1995 22
13. Stiegler H, Diehm C, Grom E et al. Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stageIV arterial occlusive disease. Vasa 1992 35 164-166 (Pubitemid 23004241)
14. Altstaedt H O., Berzewski B, Breddin H K. et al. Treatment of patients with peripheral arterial occlusive disease Fontaine stageIV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 1993 49 573-578 (Pubitemid 23236517)
15. Loosemore T M., Chalmers T C., Dormandy J A. A meta-analysis of randomized placebo control trials in Fontaine stagesIII and IV peripheral occlusive arterial disease. Int Angiol 1994 13 133-142 (Pubitemid 24248101)
16. Mangiafico R A., Malatino L S., Santonocito M et al. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication. Int J Clin Pharmacol Ther 1999 37 347-351 (Pubitemid 29338491)
17. Milio G, Coppola G, Novo S. The effects of prostaglandin E-1 in patients with intermittent claudication. Cardiovasc Hematol Disord Drug Targets 2006 6 71-76
18. Pogessi L, Comeglio M. The role of iloprost in the treatment of critical ischemia of the limbs. Ann Ital Med Int 1993 8 71S-77S
19. Gbaoui L, Kaniusas E, Szeles J et al. Effects of the auricular electrical stimulation on heart rate variablility assessed in phase space: pilot study. Vortrag: IEEE SENSORS 2008 Conference, LECCE, 26.10.200829.10.2008 Italien Ieee Sensors 2008 176-179
20. Sator-Katzenschlager S M., Michalek-Sauberer A. P-Stim auricular electroacupuncture stimulation device for pain relief. Expert Rev Med Devices 2007 4 23-32
21. Peuker E T., Filler T J. The Nerve Supply of the Human Auricle. Clin Anat 2002 15 35-37 (Pubitemid 34033535)
22. Leng G C., Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000 CD000990
23. Schönefeld E, Schönefeld T, Osada N et al. Lange femoro-popliteale Läsionen erfordern lange Stents erste Erfahrungen mit 128Protégé-Stents. Zentralbl Chir 2009 134 310-315